Experienced in Hairy Cell Leukemia (HCL)

Friedemann Honecker

Hamburg, HH, DE 
Experienced in Hairy Cell Leukemia (HCL)
Hamburg, HH, DE 
OverviewLocationsClinical Research

Overview

Friedemann Honecker practices in Hamburg, Germany. Honecker is rated as an Experienced expert by MediFind in the treatment of Hairy Cell Leukemia (HCL). Their top areas of expertise are Testicular Cancer, Testicular Yolk Sac Tumor, Germ Cell Tumor, Orchiectomy, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 65 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hairy Cell Leukemia (HCL).

Locations

Hamburg, HH 20246, Germany
Other Locations
Eppendorf, HH 20246, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drug: Denosumab
Study Phase: Phase 3
A 24 Weeks Activity Program in Patients With Early Breast Cancer Receiving Aromatase Inhibitor Therapy. A Multicenter Randomized Phase III Trial
A 24 Weeks Activity Program in Patients With Early Breast Cancer Receiving Aromatase Inhibitor Therapy. A Multicenter Randomized Phase III Trial
Enrollment Status: Completed
Publish Date: June 27, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

65 Total Publications

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: January 15, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Honecker's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile